LeuRS-IN-1 hydrochloride
LeuRS-IN-1 hydrochloride is a potent, orally active M. tuberculosis leucyl-tRNA synthetase (M.tb LeuRS) inhibitor. LeuRS-IN-1 hydrochloride has IC50 and Kd values of 0.06 μM, 0.075 μM for M.tb LeuRS, respectively. LeuRS-IN-1 hydrochloride inhibits human cytoplasmic LeuRS (IC50=38.8 μM), and HepG2 protein synthesis (EC50=19.6 μM).
For research use only. We do not sell to patients.
- CAS No.: 1364683-67-9
- Formula: C10H14BCl2NO3
- Molecular Weight:277.94
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
M.tb LeuRS 0.06 μM (IC50) |
M.tb LeuRS 0.075 μM (Kd) |
human cytoplasmic LeuRS 38.8 μM (IC50) |
HepG2 protein synthesis 19.6 μM (EC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HepG2 | EC50 |
65.8 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay
|
[PMID: 28953378] |
LeuRS-IN-1 (compound 13) hydrochloride has a MIC value of 0.02 μg/mL for M.tb H37Rv bacteria[1].
LeuRS-IN-1 (compound 3a) (48 h) hydrochloride induces HepG2 cell toxicity with an EC50 value of 65.8 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
LeuRS-IN-1 (33 mg/kg; orally 5 days a week for 4 weeks) hydrochloride reduces lung and spleen CFU values in chronic TB mice[1].
Murine pharmacokinetic parameters[1]:
| Administration | Dose (mg/kg) | Cmax (μg/ml) at 5 min |
CL (ml/h/kg) | Vss (ml/kg) | MRT (h) | AUC0-∞ (h · μg/ml) |
α-t1/2 (h) (% AUC) |
β-t1/2 (h) (% AUC) |
| i.v. | 30 | 13.6 | 582 | 3,142 | 5.4 | 51.6 | 0.10 (2) | 3.83 (98) |
| Administration | Dose (mg/kg) | Cmax (μg/ml) | Tmax (h) | AUC0-24 (h · μg/ml) |
Terminal t1/2 (h) |
Bioavailability (%) (h · μg/ml) |
Mouse PPB (%) |
| p.o. | 30 | 6.4 | 0.25 | 47.5 | 3.1 | 9.2 | 23 |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Murine GKO (C57BL/6-Ifngtm1ts) model of acute TB[1]
-
Dosage:100 mg/kg
-
Administration:Orally daily for 14 days after 10 days of infection (start) with M. tuberculosis Erdman.
-
Result:Reduced lung CFU value in mice.
-
Animal Model:Murine BALB/c model of chronic TB infection[1]
-
Dosage:33 mg/kg
-
Administration:Orally 5 days a week for 4 weeks after infection with M. tuberculosis Erdman with a low-dose aerosol 21 days prior (start).
-
Result:Reduced lung and spleen CFU values in mice.
Chemical Information
-
CAS No. 1364683-67-9
-
Molecular Weight 277.94
-
Formula C10H14BCl2NO3
-
SMILES
CCOC1=C2C([C@H](OB2O)CN)=C(C=C1)Cl.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Palencia A, et al. Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase. Antimicrob Agents Chemother. 2016;60(10):6271-6280. Published 2016 Sep 23. [Content Brief]
[2]. Li X, et al. Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656). J Med Chem. 2017 Oct 12;60(19):8011-8026. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
LeuRS-IN-1 hydrochloride Related Classifications
HY-139987A Related Classifications
Powered by Bioz